Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention
Lan Li,1 Zhenrong Ge,1 Dengke Zhang,1 Jun Kuang,2 Xiang Ma,3 Shubin Jiang1 1Coronary Care Unit, The Traditional Chinese Medicine Hospital, Xinjiang Medical University, 2Department of Cardiology, General Hospital of Xinjiang Military Command, 3Department of Cardiology, First Affiliated Hospital of X...
Main Authors: | Li L, Ge Z, Zhang D, Kuang J, Ma X, Jiang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-quadruple-therapy-including-tirofiban-in-the-tr-peer-reviewed-article-DDDT |
Similar Items
-
Effect of tirofiban combined with PCI on myocardial damage and platelet activation in patients with STEMI
by: Guo-Hua Shi
Published: (2018-01-01) -
Effect of preoperative small dose of tirofiban on PCI treatment in patients with acute coronary syndrome
by: Li Wang, et al.
Published: (2016-06-01) -
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017-03-01) -
Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection
by: Duck-Ho Goh, et al.
Published: (2016-09-01) -
A misleading diagnosis in acute coronary syndrome: tirofiban-induced alveolar hemorrhage
by: Bahadır Şarlı, et al.
Published: (2015-12-01)